106 related articles for article (PubMed ID: 19403992)
1. Effects of eicosapentaenoic acid on endothelial cell-derived microparticles, angiopoietins and adiponectin in patients with type 2 diabetes.
Nomura S; Shouzu A; Omoto S; Inami N; Ueba T; Urase F; Maeda Y
J Atheroscler Thromb; 2009 Apr; 16(2):83-90. PubMed ID: 19403992
[TBL] [Abstract][Full Text] [Related]
2. The effects of pitavastatin, eicosapentaenoic acid and combined therapy on platelet-derived microparticles and adiponectin in hyperlipidemic, diabetic patients.
Nomura S; Inami N; Shouzu A; Omoto S; Kimura Y; Takahashi N; Tanaka A; Urase F; Maeda Y; Ohtani H; Iwasaka T
Platelets; 2009 Feb; 20(1):16-22. PubMed ID: 19172517
[TBL] [Abstract][Full Text] [Related]
3. Effects of sarpogrelate, eicosapentaenoic acid and pitavastatin on arterioslcerosis obliterans-related biomarkers in patients with type 2 diabetes (SAREPITASO study).
Nomura S; Taniura T; Shouzu A; Omoto S; Suzuki M; Okuda Y; Ito T
Vasc Health Risk Manag; 2018; 14():225-232. PubMed ID: 30271161
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of eicosapentaenoic acid on insulin resistance in hyperlipidemic patients and on the postoperative course of cardiac surgery patients: the possible involvement of adiponectin.
Yamamoto T; Kajikawa Y; Otani S; Yamada Y; Takemoto S; Hirota M; Ikeda M; Iwagaki H; Saito S; Fujiwara T
Acta Med Okayama; 2014 Dec; 68(6):349-61. PubMed ID: 25519029
[TBL] [Abstract][Full Text] [Related]
5. Effect of acarbose on platelet-derived microparticles, soluble selectins, and adiponectin in diabetic patients.
Shimazu T; Inami N; Satoh D; Kajiura T; Yamada K; Iwasaka T; Nomura S
J Thromb Thrombolysis; 2009 Nov; 28(4):429-35. PubMed ID: 19137265
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of angiopoietins and cell-derived microparticles after stem cell transplantation.
Nomura S; Ishii K; Inami N; Kimura Y; Uoshima N; Ishida H; Yoshihara T; Urase F; Maeda Y; Hayashi K
Biol Blood Marrow Transplant; 2008 Jul; 14(7):766-74. PubMed ID: 18541195
[TBL] [Abstract][Full Text] [Related]
7. Effects of eicosapentaenoic acid on platelet activation markers and cell adhesion molecules in hyperlipidemic patients with Type 2 diabetes mellitus.
Nomura S; Kanazawa S; Fukuhara S
J Diabetes Complications; 2003; 17(3):153-9. PubMed ID: 12738400
[TBL] [Abstract][Full Text] [Related]
8. Effect of valsartan on monocyte/endothelial cell activation markers and adiponectin in hypertensive patients with type 2 diabetes mellitus.
Nomura S; Shouzu A; Omoto S; Nishikawa M; Fukuhara S; Iwasaka T
Thromb Res; 2006; 117(4):385-92. PubMed ID: 15896827
[TBL] [Abstract][Full Text] [Related]
9. Correlation between adiponectin and reduction of cell adhesion molecules after pitavastatin treatment in hyperlipidemic patients with type 2 diabetes mellitus.
Nomura S; Shouzu A; Omoto S; Inami N; Tanaka A; Nanba M; Shouda Y; Takahashi N; Kimura Y; Iwasaka T
Thromb Res; 2008; 122(1):39-45. PubMed ID: 17920663
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-19 and angiopoietin-2 can enhance angiogenesis of diabetic complications.
Li L; Yu ZH; Qian L; Xu JY; Liu F; Zhao GC; Zhang L; Gu HM; Zhang SJ; Meng J
J Diabetes Complications; 2016 Mar; 30(2):386-7. PubMed ID: 26657726
[TBL] [Abstract][Full Text] [Related]
11. Serum angiopoietin-2 is associated with angiopathy in type 2 diabetes mellitus.
Li L; Qian L; Yu ZQ
J Diabetes Complications; 2015; 29(4):568-71. PubMed ID: 25754501
[TBL] [Abstract][Full Text] [Related]
12. Eicosapentaenoic acid ethyl ester improves endothelial dysfunction in type 2 diabetic mice.
Takenouchi Y; Ohtake K; Nobe K; Kasono K
Lipids Health Dis; 2018 May; 17(1):118. PubMed ID: 29788974
[TBL] [Abstract][Full Text] [Related]
13. Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.
Lip PL; Chatterjee S; Caine GJ; Hope-Ross M; Gibson J; Blann AD; Lip GY
Br J Ophthalmol; 2004 Dec; 88(12):1543-6. PubMed ID: 15548809
[TBL] [Abstract][Full Text] [Related]
14. Circulating CD36+ microparticles are not altered by docosahexaenoic or eicosapentaenoic acid supplementation.
Phang M; Thorne RF; Alkhatatbeh MJ; Garg ML; Lincz LF
Nutr Metab Cardiovasc Dis; 2016 Mar; 26(3):254-60. PubMed ID: 26803595
[TBL] [Abstract][Full Text] [Related]
15. Effects of atorvastatin on circulating CD34+/CD133+/ CD45- progenitor cells and indices of angiogenesis (vascular endothelial growth factor and the angiopoietins 1 and 2) in atherosclerotic vascular disease and diabetes mellitus.
Jaumdally RJ; Goon PK; Varma C; Blann AD; Lip GY
J Intern Med; 2010 Apr; 267(4):385-93. PubMed ID: 19754853
[TBL] [Abstract][Full Text] [Related]
16. Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis.
Lim HS; Lip GY; Blann AD
Atherosclerosis; 2005 May; 180(1):113-8. PubMed ID: 15823283
[TBL] [Abstract][Full Text] [Related]
17. Low intravitreal angiopoietin-2 and VEGF levels in vitrectomized diabetic patients with simvastatin treatment.
Tuuminen R; Sahanne S; Loukovaara S
Acta Ophthalmol; 2014 Nov; 92(7):675-81. PubMed ID: 24506800
[TBL] [Abstract][Full Text] [Related]
18. Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet.
Flachs P; Mohamed-Ali V; Horakova O; Rossmeisl M; Hosseinzadeh-Attar MJ; Hensler M; Ruzickova J; Kopecky J
Diabetologia; 2006 Feb; 49(2):394-7. PubMed ID: 16397791
[TBL] [Abstract][Full Text] [Related]
19. Incretin treatment and atherosclerotic plaque stability: Role of adiponectin/APPL1 signaling pathway.
Barbieri M; Marfella R; Esposito A; Rizzo MR; Angellotti E; Mauro C; Siniscalchi M; Chirico F; Caiazzo P; Furbatto F; Bellis A; D'Onofrio N; Vitiello M; Ferraraccio F; Paolisso G; Balestrieri ML
J Diabetes Complications; 2017 Feb; 31(2):295-303. PubMed ID: 27771154
[TBL] [Abstract][Full Text] [Related]
20. Quinapril treatment increases insulin-stimulated endothelial function and adiponectin gene expression in patients with type 2 diabetes.
Hermann TS; Li W; Dominguez H; Ihlemann N; Rask-Madsen C; Major-Pedersen A; Nielsen DB; Hansen KW; Hawkins M; Kober L; Torp-Pedersen C
J Clin Endocrinol Metab; 2006 Mar; 91(3):1001-8. PubMed ID: 16352688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
